La cadena de opciones muestra datos clave de las opciones de acciones de TEN Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para TEN Holdings..

TEN Holdings (NASDAQ:XHLD) Bolsa, Cadena de Opciones

TEN Holdings

TEN Holdings Inc is a provider of event planning, production, and broadcasting services. The company produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by its Xyvid Pro Platform. Physical events involve live streaming and video recording of physical events. The Company operates business as one operating segment which includes two revenue types: Hybrid and Virtual Events and Physical Events.

Stock,Market,Graph,Trading,Analysis,Investment,Financial,,Stock,Exchange,Financial

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABSI

ALLT

ALUR

ASNS

AXDX

DBVT

DEVS

FNGR

GRAL

LRHC

LUCY

PLRZ

UBER

WBUY

XHLD

XTKG

Las acciones de Everus Construction Group suben un 14,7 % tras superar expectativas de ganancias y ventas en el primer trimestre.

Acciones de Everus Construction (ECG) se disparan un 15%; Aquí están 20 acciones que se mueven en premercado

Movimiento de acciones

Intraday Update

AUID

BHAT

BNTC

GCTK

INNV

MCVT

OUST

PNBK

PSTV

RVSB

TNMG

USAR

Ouster sorprende con resultados mejores de lo esperado y sus acciones suben un 8,95%. Descubre las acciones que dominan el premercado.

Las acciones de Ouster (OUST) suben un 9%; Aquí están 20 acciones que se mueven en el premercado de EE.UU.

First sublingual pre-workout single-serving supplement that delivers 50mg of caffeine rapidly to the body, is now available to order via Aspire's new direct-to-consumer shopping experience
ESTERO, FL / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / July 31, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced the rollout of its new e-commerce solution, <a href="https://pr.report/cuce">buzzbomb.buzz</a> with BUZZ BOMB&#x2122; as its featured launch product. This new seamless direct-to-consumer shopping experience allows consumers to order BUZZ BOMB&#x2122; on the Aspire platform and have them shipped directly to their door with access to exclusive promotions, and customer support. To celebrate the launch, customers who register for Aspire's e-commerce site will have first access to special pricing, free shipping offers, and other promotions. The site features an introductory sample pack of four flavors as well as 30-packs in various configurations.

ASBP

Aspire Biopharma Launches Direct-To-Consumer Site Featuring BUZZ BOMB, First Rapid-Delivery Sublingual Pre-Workout Supplement

WIIM

SHAK

Shake Shack shares are trading lower following the release of its Q2 financial results.

Short Sellers

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

Currenc Group Retains Shareholder Intelligence Services To Assist In Monitoring And Investigating Potential Naked Short Selling

Commercial-Scale AirSCWO System Consistently Destroys PFAS in Biosolids to Non-Detectable Levels
Disposal of PFAS Contaminated Biosolids from Wastewater Treatment Plants is Growing Nationwide Issue
DURHAM, N.C., July 31, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) ("374Water") (the "Company"), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced the successful waste destruction of PFAS in biosolids utilizing our commercial-scale AirSCWO system. These waste destruction results showcase the effectiveness of our AirSCWO technology to destroy one of the hardest, most problematic waste streams containing toxic "forever chemicals", producing effluent with PFAS concentrations at non-detectable levels.
Biosolids are the organic materials that remain after effluent has been treated at a wastewater treatment plant. Biosolids are a necessary byproduct of wastewater treatment, but growing concerns over toxins, environmental impact, and limited disposal options have turned biosolid management into a pressing national issue.
Especially concerning are per- and polyfluoroalkyl ("PFAS") contaminated wastes. PFAS "forever chemicals" are a group of thousands of synthetic chemicals which are persistent and hazardous. Toxic PFAS are found in many everyday products that are included in the wastewater stream from homes and businesses. When biosolids are disposed of via land application, PFAS can contaminate soil, crops, groundwater, and livestock, creating major public health and environmental risks. States and municipalities are beginning to limit the amount of waste that can be disposed of via land application, landfills are accepting less of this form of waste, and transportation costs and disposal fees are also increasing as disposal options become more limited. Wastewater treatment facilities are now increasingly looking to innovative waste destruction technologies, such as our AirSCWO system, to fully eliminate and destroy PFAS contaminated biosolids resulting from treatment in wastewater facilities and eliminate the need for further downstream processing.

SCWO

374Water's AirSCWO System Achieves Commercial-Scale Destruction Of PFAS In Biosolids To Non-Detectable Levels

SPSC

SPC Commerce shares are trading lower following the release of its Q2 financial results. Also, Needham cut its price target on the stock from $210 to $160.

<ul>
<li>Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences</li>
<li>Provides vital insights through sophisticated genomic sequencing and analysis of Frenova's My Reason&#xAE; genomic and clinical data registry</li>
<li>Paves way for advances in precision kidney disease care, novel therapies, and diagnostics</li>
</ul>
&nbsp;

Biotech

General

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Collaborates With GENEWIZ To Advance Genomics-Driven, Precision Kidney Disease Care

DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) ("DDC" or the "Company"), an Asian consumer-first company at the forefront of corporate bitcoin acquisition and treasury management, today announced a partnership with Matrixport, the world's leading all-in-one hub of crypto financial services, to enhance its institutional-grade custody solutions further.
The Company will integrate Cactus Custody, a regulated digital asset custodian and a subsidiary of Matrixport Group, into its dynamic custodian network, reinforcing its robust asset protection, compliance, and operational flexibility as its Bitcoin holdings continue to grow.
 &nbsp;

DDC Enterprise Partners With Matrixport To Enhance Its Institutional-Grade Custody Solutions Further

TAL Education Group shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

Corporate treasuries and spot ETFs are rapidly consolidating their hold on Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), with combined on-chain and off-chain holdings <a href="https://www.benzinga.com/money/what-is-ethereum-etf">now surpassing $32 billion</a>.
Data compiled by SER shows that 64 entities, spanning publicly listed firms, exchanges, DeFi protocols, nonprofits and governments, collectively hold 2.73 million ETH in their treasuries, valued at over $10.5 billion.
This marks a notable shift in asset allocation strategies, particularly as companies like Bitmine Immersion Tech (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>), SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>), and Ether Machine now individually surpass the Ethereum Foundation in ETH holdings. 
Bitmine alone controls 625,000 ETH, followed by SharpLink with 438,200 ETH and Ether Machine with 334,800 ETH.
U.S. spot Ethereum ETFs have seen explosive growth, with net inflows totaling $5.38 billion over a 19-day streak that began on July 3.
This matches a prior record streak from May but significantly exceeds it in dollar terms. 
BlackRock's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETHA#NASDAQ">ETHA</a>) fund leads the pack, pulling in $4.19 billion during this run and controlling over 3 million ETH — about 2.5% of total ETH supply.
Altogether, U.S. spot Ethereum ETFs now hold approximately 5.7 million ETH, valued near $22 billion. 
That figure represents 4.7% of Ethereum's circulating supply, per data from CoinGlass. 
These allocations make ETFs the single largest collective holder of ETH assets, outpacing even corporate treasuries.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46729976/300-growth-in-high-inflation-nations-why-stablecoins-are-booming-where-fiat-is-failing">300% Growth In High-Inflation Nations: Why Stablecoins Are Booming Where Fiat Is Failing</a>
Why It Matters: This trend of institutional accumulation has been supported by recent regulatory shifts.
On Tuesday, the U.S. SEC approved in-kind redemptions for crypto ETFs, allowing authorized participants to exchange ETH and BTC directly for ETF shares, rather than cash, a move that aligns the structure of crypto funds with traditional markets and improves tax efficiency.
Additionally, BlackRock received acknowledgment from the SEC for its 19b-4 filing to enable staking within its ETH ETF, setting the stage for a new layer of yield-generating exposure for institutional investors.
Standard Chartered's digital assets head Geoffrey Kendrick predicts ETH treasuries could grow to control as much as 10% of the total supply, citing yield-generating opportunities like staking and <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46699508/ethereum-treasuries-could-soon-own-10-of-all-eth-standard-chartered">deeper DeFi integration. </a>
However, analysts at Bernstein caution that staking strategies, while lucrative, come with liquidity and smart contract risk.
The current momentum underscores a new phase for Ethereum, not only as a tech stack for decentralized applications but increasingly as a yield-bearing, institutionally held financial asset.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46723859/trumps-advisors-just-laid-out-a-crypto-blueprint-heres-whats-in-it">Trump&#8217;s Advisors Just Laid Out A Crypto Blueprint—Here&#8217;s What&#8217;s In It</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

BMNR

ETHA

SBET

Ethereum ETFs, Treasury Companies Now Hold Over $32B In ETH: Here's What's Driving The Frenzy

ALHC

TransMedics Group shares are trading higher after the company reported better-than-expected Q2 EPS results and raised its FY25 sales guidance above estimates.

<ul>
<li>Eagle will become the first domestic uranium resource exploration company with Small Modular Reactor (SMR) technology to go public, with a clear path to development supported by a substantial uranium resource, extensive drilling data, and a strategically located project with nearby existing infrastructure.</li>
<li>Partnering with Spring Valley II, whose team brought NuScale Power public in a highly successful deal and ushered in this new wave of enthusiasm by institutional investors in the nuclear industry.</li>
<li>The Aurora deposit has a near-surface resource comprised of over 50 million pounds1 of uranium, generated from more than 500 holes drilled to date; Eagle is targeting commencement of a pre-feasibility study at Aurora in 2026.</li>
<li>Adjacent to Aurora is the Cordex deposit, which has had over 100 holes drilled into it and offers significant upside of additional uranium resources; Cordex also lies within Eagle's land package.</li>
<li>Eagle also holds proprietary SMR technology, positioning it for next-generation, distributed nuclear energy deployment and optionality to pursue vertical integration through a licensing model.</li>
<li>The proposed transaction values Eagle at a pro-forma equity value of $312 million.</li>
<li>A fundamental institutional investor to invest approximately $30 million in Series A Convertible Preferred Stock at closing.</li>
<li>The transaction includes no minimum cash condition, increasing certainty of closing.</li>
</ul>

SVII

Eagle Energy Metals To Go Public Via Business Combination With Spring Valley Acquisition Corp. II Under New Ticker "NUCL"

TMDX

TransMedics Group shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.

Oragenics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NYSE">OGEN</a>), a clinical-stage biotechnology company pioneering intranasal drug delivery for neurological conditions, today announced the selection of Southern Star Research as its Clinical Research Organization (CRO) for the upcoming Phase IIa clinical trial of ONP-002, the company's lead drug candidate for concussion.
Southern Star Research is a globally recognized, full-service CRO with a proven track record in delivering early-phase trials across Australia and Asia-Pacific. Their deep operational expertise, regulatory knowledge, and hands-on site management capabilities will support the execution of Oragenics' randomized, double-blind, placebo-controlled Phase IIa study evaluating ONP-002 in adults with mild traumatic brain injury (mTBI).
ONP-002 is a proprietary intranasal neurosteroid with a novel delivery mechanism designed to enhance drug delivery to the brain while minimizing systemic exposure. In preclinical models, ONP-002 demonstrated reduced brain inflammation, improved memory and cognition, and recovery of sensory-motor function.
The Phase IIa trial will evaluate the safety, tolerability, pharmacokinetics (PK), and early pharmacodynamic (PD) effects of ONP-002 in adults with mTBI.

OGEN

Oragenics Selects Southern Star Research As Clinical Research Organization For Upcoming Phase IIa Clinical Trial Of ONP-002, Lead Drug Candidate For Concussion

Fold Holdings And Blackhawk Network To Expand Distribution Of Fold Bitcoin Gift Card

TOP Ships Inc. (the "Company" or "TOP Ships") (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tops#NYSE">TOPS</a>), an international owner and operator of modern, fuel-efficient "ECO" tanker vessels, announced today that the expected distribution date for the common shares of
TOP Ships Inc. (the "Company" or "TOP Ships") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOPS#NYSE">TOPS</a>), an international owner and operator of modern, fuel-efficient "ECO" tanker vessels, announced today that the expected distribution date for the common shares of Rubico Inc. ("Rubico") is August 1, 2025.
Rubico common shares are expected to commence trading on a standalone basis on the Nasdaq Capital Market on August 4, 2025, the first trading day after the date of distribution, under the ticker "RUBI".
As previously announced, TOP Ships intends through Rubico to effect a spin-off of two of its vessels, the M/T Eco Malibu and M/T Eco West Coast, each a modern, high specification, scrubber-fitted and fuel-efficient 157,000 dwt Suezmax tanker. As part of the spin-off transaction, TOP Ships intends to distribute 100% of the common shares of Rubico pro rata to its securityholders of record as of June 16, 2025. As previously announced, the NYSE American established an ex-distribution date for the distribution of Rubico common shares of June 16, 2025. Beginning on that date, TOP Ships common shares traded without an entitlement by the purchaser of such shares to Rubico common shares distributed in connection with the spin-off.

TOPS

TOP Ships Announces That It Will Distribute 100% Of The Common Shares Of Rubico Inc To Its Securityholders On August 1, 2025, As Part Of A Previously Announced Spin-off Involving Two Of Its Modern, Fuel-efficient Suezmax Tankers

UBS analyst Thomas Wadewitz maintains C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) with a Buy and raises the price target from $129 to $133.

Price Target

Analyst Ratings

CHRW

UBS Maintains Buy on C.H. Robinson Worldwide, Raises Price Target to $133

Dividends

VIVK

Vivakor To Issue Special Dividend On Aug. 20, 2025

Financing

NSPR

InspireMD Announces It Has Raised ~$58M In Gross Proceeds Through PIPE Financing

Kopin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced it has received a contract update for development Phase 2 of the Next-Generation Short-Range Interceptor (NGSRI) Visual Display Subsystem (VDS) from Lockheed Martin. As a global defense technology company driving innovation and advancing scientific discovery, Lockheed Martin accelerates the delivery of transformative technologies through 21st Century Security&#xAE;.
The NGSRI program aims to advance the capabilities of short-range missile defense systems. This update funds the build and test of the new high-resolution VDS assembly that includes Kopin's proprietary organic light emitting diode (OLED) microdisplay, drive electronics, and optical designs for integration into the Command Launch Assembly (CLA)—a key system in the U.S. Army's NGSRI initiative.
Under the Phase 2 contract update, Kopin will deliver fully assembled "All-Up Round" units—VDS assemblies for use in a variety of simulated and operational missile launch test scenarios.

KOPN

Kopin Receives Contract Update For Development Phase 2 Of Next-Gen Short-Range Interceptor Visual Display Subsystem From Lockheed Martin

As anticipation builds for Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) upcoming earnings report, investors are closely watching how the tech giant&#8217;s performance might impact its stock and dividend yields. Apple will release earnings results for the third quarter after the <a href="https://www.benzinga.com/earnings">closing bell on Thursday.</a>
Analysts expect the iPhone maker to report quarterly earnings of $1.42 per share, compared to $1.40 per share in the same period last year. Apple projects to report quarterly revenue of $89.04 billion, compared to $85.78 billion a year earlier, according to data from Benzinga Pro.
On Wednesday, Wedbush analyst Daniel Ives reiterated Apple with an Outperform rating and maintained a $270 price target.
With the recent buzz around Apple, some investors may be eyeing potential gains from the company's dividends too. As of now, Apple offers an annual dividend yield of 0.50%, which is a semi-annual dividend amount of 26 cents per share ($1.04 a year). &nbsp;
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $1,206,009 or around 5,769 shares. For a more modest $100 per month or $1,200 per year, you would need $241,244 or around 1,154 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($1.04 in this case). So, $6,000 / $1.04 = 5,769 ($500 per month), and $1,200 / $1.04 = 1,154 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
AAPL Price Action: Shares of Apple fell 1.1% to close at $209.05 on Wednesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46733987/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Delivering High-Dividend Yields</a></li>
</ul>
Photo: hanohiki via Shutterstock.com

Earnings

Long Ideas

AAPL

How To Earn $500 A Month From Apple Stock Ahead Of Q3 Earnings

Press Releases

TEN Holdings, Inc. Reports Full Year 2024 Financial Results

TEN Holdings, Inc. Announces Participation in the LD Micro Invitational XV

Entertainment

TEN Holdings' Subsidiary Delivers Scalable Solutions with Zero Downtime for a Big 4 Consulting Firm's Global Broadcasts

TEN Holdings Sponsors CancerCare® Spring Gala in Support of Critical Cancer Support Services

Small Cap

TEN Holdings Announces Participation in The D. Boral Capital Inaugural Global Conference

TEN Holdings Recognized as a "High Performer" and "Easy to Do Business With" in G2's Spring 2025 Reports

TEN Holdings Inc. Reports First Quarter 2025 Financial Results

TEN Holdings Announces Participation in Investor Conferences for June 2025

TEN Holdings Announces Early Adopter Program for New SaaS Product, Ten Events Pro

Comments

TEN Holdings

TEN Holdings (XHLD) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL